Results 1 to 10 of about 609 (142)

Pharmacokinetics, pharmacodynamics, and safety of ciprofol emulsion in Chinese subjects with normal or impaired renal function [PDF]

open access: yesFrontiers in Pharmacology, 2023
Background: Ciprofol, a novel sedative–hypnotic drug, has been approved for its use in inducing and maintaining general anesthesia, as well as for providing sedation.Methods: In this phase I, single-center, parallel, controlled, open-label clinical trial,
Jun Tao   +11 more
exaly   +5 more sources

Age-related reduction in ciprofol requirement for loss of consciousness during anesthesia induction: a prospective cohort study [PDF]

open access: yesFrontiers in Medicine
BackgroundCiprofol, a novel intravenous anesthetic for procedural sedation and general anesthesia, characterized by rapid onset of action, lower rates of injection pain and effective sedation at lower doses, is a promising alternative to propofol ...
Yu-Gang Lu   +6 more
doaj   +2 more sources

Ciprofol attenuates the isoproterenol-induced oxidative damage, inflammatory response and cardiomyocyte apoptosis

open access: yesFrontiers in Pharmacology, 2022
Background and Purpose: Ciprofol (HSK3486), a novel 2,6-disubstituted phenol derivative, is a new intravenous anesthetic compound with a similar chemical structure to propofol.
Yunzhao Yang   +5 more
exaly   +3 more sources

A chronopharmacological comparison of ciprofol and propofol: focus on sedation and side effects [PDF]

open access: yesFrontiers in Molecular Neuroscience
Propofol is a commonly used intravenous anesthetic in clinical practice, while ciprofol, a propofol derivative, also targets GABAA receptors with enhanced anesthetic potency.
Xuehan Li   +11 more
doaj   +3 more sources

ED50 of ciprofol combined with different doses of remifentanil during upper gastrointestinal endoscopy in school-aged children: a prospective dose-finding study using an up-and-down sequential allocation method [PDF]

open access: yesFrontiers in Pharmacology
ObjectiveThis study aimed to determine the 50% effective dose (ED50) of ciprofol when combined with different doses of remifentanil for upper gastrointestinal endoscopy of school-age children and to evaluate its safety.MethodsThis study involved school ...
Xu Zhang   +4 more
doaj   +3 more sources

Population pharmacokinetics of a single bolus of ciprofol in Chinese pediatric patients [PDF]

open access: yesBMC Anesthesiology
Background Ciprofol is a recently developed sedative similar to propofol, but there is a lack of bolus pharmacokinetic data for ciprofol in children.
Sicong Wang   +7 more
doaj   +2 more sources

Efficacy and safety of ciprofol-remifentanil versus propofol-remifentanil during fiberoptic bronchoscopy: A prospective, randomized, double-blind, non-inferiority trial

open access: yesFrontiers in Pharmacology, 2022
Objective: Ciprofol is a novel 2,6-disubstituted phenol derivative that has improved pharmacokinetic and pharmacodynamic properties compared with propofol.
Bin Wu   +5 more
exaly   +3 more sources

A case report of ciprofol overdose during anesthesia/analgesia and literature review: clinical presentation, blood pressure, and management

open access: yesJournal of International Medical Research, 2022
Ciprofol is a novel intravenous anesthetic agent and a highly selective gamma-aminobutyric acid-A receptor agonist, similar to propofol. This is the first report about ciprofol overdose occurring during the maintenance phase of anesthesia for a surgical ...
Mengchang Yang
exaly   +2 more sources

Ciprofol injection in patients receiving non-invasive positive pressure ventilation: a retrospective study [PDF]

open access: yesFrontiers in Pharmacology
ObjectThis study aims to compare the efficacy and safety of ciprofol versus propofol in sedation for patients undergoing non-invasive positive pressure ventilation (NPPV), with a focus on evaluating sedative efficiency and systematically comparing the ...
DaLong Zhang   +5 more
doaj   +2 more sources

Clinical effect of different doses of ciprofol for induction of general anesthesia in elderly patients: A randomized, controlled trial

open access: yesPharmacology Research and Perspectives, 2023
Ciprofol is a newly developed intravenous anesthetic agent with improved pharmacokinetic properties. Compared to propofol, ciprofol exhibits stronger binding to the GABAA receptor and elicits a greater enhancement of GABAA receptor‐mediated neuronal ...
Gongchen Duan, Haiyan Lan, Yini Wu
exaly   +2 more sources

Home - About - Disclaimer - Privacy